Evidence map›Paper›PMID 30112352›Full record

ArticleClinical and experimental vaccine research2018

Development of dual reporter imaging system for

Young-Hwa Kim, Pil-Gu Park, Sang-Hwan Seo, Kee-Jong Hong, Hyewon Youn

Open access · diamondAbstract read
In one paragraph

Article in Clinical and experimental vaccine research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Young-Hwa KimDepartment of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-0517-9559
Pil-Gu ParkDepartment of Microbiology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-3024-3439
Sang-Hwan SeoInternational Vaccine Institute, Seoul, Korea.ORCID https://orcid.org/0000-0002-4518-8858
Kee-Jong HongInterpark Bio-Convergence Center, I-Market-Korea, Seoul, Korea.ORCID https://orcid.org/0000-0003-2054-7014
Hyewon YounDepartment of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1006-2689
Seoul National University · KRAdvanced Institute of Convergence Technology · KRInternational Vaccine Institute · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeStudy on the pathogen and the pathogen-related disease require the information at both cellular and organism level. However, lack of appropriate high-quality antibodies and the difference between the experimental animal models make it difficult to analyze MATERIALS AND

methodsA dual reporter plasmid using GFP-Lux with putative bacterioferritin promoter (pBfr) was constructed and transformed to

resultsWe visualized the bacterial replication of

conclusionWe successfully established dual reporter labeled

Indexed as

Francisella tularensisIn vivo imagingVaccine

Identifiers

PMID30112352
PMCPMC6082674
OpenAlexW2885359298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.